Anika Therapeutics
ANIK
#9072
Rank
A$0.26 B
Marketcap
A$19.95
Share price
-2.50%
Change (1 day)
35.97%
Change (1 year)
Categories

Anika Therapeutics (ANIK) - Total debt

Total debt on the balance sheet as of June 2026 : A$37.92 Million

According to Anika Therapeutics's latest financial reports the company's total debt is A$37.92 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Anika Therapeutics - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$39.18 M-6%
2024-12-31A$41.69 M2.39%
2023-12-31A$40.71 M-10.3%
2022-12-31A$45.39 M57.05%
2021-12-31A$28.9 M-1.07%
2020-12-31A$29.21 M-9.12%
2019-12-31A$32.14 M
2018-12-31N/A
2012-12-31A$9.23 M-15.43%
2011-12-31A$10.92 M-13.32%
2010-12-31A$12.6 M-21.39%
2009-12-31A$16.03 M-29.32%
2008-12-31A$22.67 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$67.06 B 176,735.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$42.28 B 111,397.03%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
A$22.44 B 59,076.24%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
A$53.97 M 42.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$3.22 B 8,401.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Hill-Rom
HRC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA